Indian pharmaceutical market saw a late surge in June, with growth during the quarter primarily driven by cardiac, ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Export of Indian medical devices to the UK went up by 13 per cent in FY24 as compared to the previous year. These devices ...

India has the highest number of U.S. Food and Drug Administration-approved pharmaceutical plants outside of the U.S., and pharmaceutical exports from India accounted for nearly $30 billion last year.

The deal, which eliminates tariffs on most finished pharmaceutical products and medical devices, is expected to boost India’s exports to the UK valued at over $914 million grew 18% year-on-year (YoY) ...

This has generated discussion about its effects on the Indian pharma industry. Indian pharma industry experts have provided an overview based on available sources. Vikas Nim, pharma industry ...

India has the potential to turn that principle into practice by making the next generation of therapies not only practical but also accessible and affordable. If it succeeds, India won’t just lead the ...

The deal eliminates tariff barriers and aims to ease regulatory processes, creating room for Indian companies to expand in ...

India's pharmaceutical industry boasts global stature as the 'Pharmacy of the World' but faces significant domestic challenges from informal credit systems. Here's why ...

PharmaHopers explains the booming Indian pharma distributorship market, driven by rising demand, tech adoption, and ...

The India-UK trade agreement heralds significant developments in the pharmaceutical sector, fostering collaboration in drug imports and research. The deal boosts economic ties, strengthens supply ...

YANGON: The Embassy of India in Myanmar, in collaboration with the India-Myanmar Chamber of Commerce and Industry (IMCCI), hosted the "PHARMA CONNECT 2025" event on the evening of July 25 at the Pan ...